v3.25.2
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2025
Dec. 31, 2024
Current Assets:    
Cash $ 72,086 $ 1,530,924
Prepaid expenses and other current assets 378,749 184,873
Vendor deposits 98,234
Total Current Assets 549,069 1,715,797
In-process research and development 18,647,903 18,647,903
Vendor deposit 69,477 178,476
Deferred offering costs 374,662 57,238
Total Assets 19,641,111 20,599,414
Current Liabilities:    
Accounts payable 9,774,230 9,337,267
Accrued expenses and other current liabilities 2,915,448 1,894,041
Total Current Liabilities 12,689,678 11,231,308
Deferred tax liability 851,659 851,659
Total Liabilities 13,541,337 12,082,967
Commitments and contingencies (Note 6)
Stockholders’ Equity:    
Common stock 487 251
Additional paid-in-capital 123,207,260 121,155,922
Accumulated deficit (117,100,806) (112,632,559)
Treasury stock, at cost, 7 shares at June 30, 2025 and December 31, 2024, (7,168) (7,168)
Total Stockholders’ Equity 6,099,774 8,516,447
Total Liabilities and Stockholders’ Equity 19,641,111 20,599,414
Series A Preferred Stock [Member]    
Stockholders’ Equity:    
Preferred stock
Series B Preferred Stock [Member]    
Stockholders’ Equity:    
Preferred stock $ 1 $ 1